An extracellular stochastic model of early HIV infection and the formulation of optimal treatment policy

Samira Khalili, Antonios Armaou

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The problem of scheduling optimal treatment strategies for patients at the early stage of human immunodeficiency virus (HIV) infection is investigated. Unlike patients with an established HIV infection, complete eradication of the infection is still possible at this stage and treatment can further increase the probability of eradication. However, high dosages of drugs should be avoided, if possible, because of toxic side effects. Stochastic simulation is capable of determining the infection establishment probability at the early infection stage. Consequently, to obtain acceptable treatment strategies, an optimization problem was formulated, employing a stochastic model to predict the response of an average patient to treatment. Optimal treatment strategies for prompt and also a few days latency in treatment initiation were computed. These strategies were compared with constant treatment strategies and were shown to be more beneficial in silico, i.e., they either decreased the infection establishment probability or the dosage of the drugs.

Original languageEnglish (US)
Pages (from-to)4361-4372
Number of pages12
JournalChemical Engineering Science
Volume63
Issue number17
DOIs
StatePublished - Sep 1 2008

Fingerprint

Stochastic models
Viruses
Poisons
Pharmaceutical Preparations
Scheduling

All Science Journal Classification (ASJC) codes

  • Chemistry(all)
  • Chemical Engineering(all)
  • Industrial and Manufacturing Engineering

Cite this

@article{136d0b01cfcc4b268f01e66d7721e242,
title = "An extracellular stochastic model of early HIV infection and the formulation of optimal treatment policy",
abstract = "The problem of scheduling optimal treatment strategies for patients at the early stage of human immunodeficiency virus (HIV) infection is investigated. Unlike patients with an established HIV infection, complete eradication of the infection is still possible at this stage and treatment can further increase the probability of eradication. However, high dosages of drugs should be avoided, if possible, because of toxic side effects. Stochastic simulation is capable of determining the infection establishment probability at the early infection stage. Consequently, to obtain acceptable treatment strategies, an optimization problem was formulated, employing a stochastic model to predict the response of an average patient to treatment. Optimal treatment strategies for prompt and also a few days latency in treatment initiation were computed. These strategies were compared with constant treatment strategies and were shown to be more beneficial in silico, i.e., they either decreased the infection establishment probability or the dosage of the drugs.",
author = "Samira Khalili and Antonios Armaou",
year = "2008",
month = "9",
day = "1",
doi = "10.1016/j.ces.2008.05.033",
language = "English (US)",
volume = "63",
pages = "4361--4372",
journal = "Chemical Engineering Science",
issn = "0009-2509",
publisher = "Elsevier BV",
number = "17",

}

An extracellular stochastic model of early HIV infection and the formulation of optimal treatment policy. / Khalili, Samira; Armaou, Antonios.

In: Chemical Engineering Science, Vol. 63, No. 17, 01.09.2008, p. 4361-4372.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An extracellular stochastic model of early HIV infection and the formulation of optimal treatment policy

AU - Khalili, Samira

AU - Armaou, Antonios

PY - 2008/9/1

Y1 - 2008/9/1

N2 - The problem of scheduling optimal treatment strategies for patients at the early stage of human immunodeficiency virus (HIV) infection is investigated. Unlike patients with an established HIV infection, complete eradication of the infection is still possible at this stage and treatment can further increase the probability of eradication. However, high dosages of drugs should be avoided, if possible, because of toxic side effects. Stochastic simulation is capable of determining the infection establishment probability at the early infection stage. Consequently, to obtain acceptable treatment strategies, an optimization problem was formulated, employing a stochastic model to predict the response of an average patient to treatment. Optimal treatment strategies for prompt and also a few days latency in treatment initiation were computed. These strategies were compared with constant treatment strategies and were shown to be more beneficial in silico, i.e., they either decreased the infection establishment probability or the dosage of the drugs.

AB - The problem of scheduling optimal treatment strategies for patients at the early stage of human immunodeficiency virus (HIV) infection is investigated. Unlike patients with an established HIV infection, complete eradication of the infection is still possible at this stage and treatment can further increase the probability of eradication. However, high dosages of drugs should be avoided, if possible, because of toxic side effects. Stochastic simulation is capable of determining the infection establishment probability at the early infection stage. Consequently, to obtain acceptable treatment strategies, an optimization problem was formulated, employing a stochastic model to predict the response of an average patient to treatment. Optimal treatment strategies for prompt and also a few days latency in treatment initiation were computed. These strategies were compared with constant treatment strategies and were shown to be more beneficial in silico, i.e., they either decreased the infection establishment probability or the dosage of the drugs.

UR - http://www.scopus.com/inward/record.url?scp=54249129265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249129265&partnerID=8YFLogxK

U2 - 10.1016/j.ces.2008.05.033

DO - 10.1016/j.ces.2008.05.033

M3 - Article

AN - SCOPUS:54249129265

VL - 63

SP - 4361

EP - 4372

JO - Chemical Engineering Science

JF - Chemical Engineering Science

SN - 0009-2509

IS - 17

ER -